Home › MedImmune, NIST announce 5-year partnership for biological drug research
 

Keywords :   


MedImmune, NIST announce 5-year partnership for biological drug research

2015-02-21 07:48:20| Biotech - Topix.net

Gaithersburg-based biotech MedImmune and the U.S Department of Commerce's National Institute of Standards and Technology, NIST, announced Friday a five-year joint agreement to research tools to develop new drugs or therapies, or make existing therapies more effective. The project is focused on biopharmaceuticals, drugs and treatments derived from biological, rather than chemical, sources.

Tags: research drug partnership biological

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
10.05Farm Progress America, May 10, 2024
10.05Farm Progress America, May 10, 2024
10.05Comcast releases research on how viewers discover new TV content
10.05Samba TV uses GenAI to provide actionable context for video ads
10.05Roku unveils screensaver ad integrations, ad partnerships and fresh content
10.05Samsung TV Plus partners with MLB, PGA Tour, F1 and ONE Championship
10.05UK emerged from recession at start of year
10.05UK economy out of recession, official figures show
More »